Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricBMYBristol Myers SquibbPFEPfizerMRKMerck & Co.
Snapshot
Price$54.70$25.08$115.48
Market cap$110.27B$143.68B$281.24B
Valuation
P/E18.5x19.1x31.4x
Forward P/E14.6x20.2x44.8x
Growth
Revenue growth1.8%1.4%2.9%
EPS growth26.3%-5.3%-48.3%
Profitability
Net margin12.3%11.8%13.6%
ROE41.6%8.4%17.9%
Balance sheet & cash
Debt / equity2.44x0.75x0.94x
Free cash flow yield15.4%11.2%2.9%
Dividend yield4.5%6.6%3.0%
Verdict
Investment ratingFavorable· 60Neutral· 48Weak· 40

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearBMYtoday $55PFEtoday $25MRKtoday $115
2027$51.80 – $75.98+39% CAGR$19.19 – $28.14+12% CAGR$88.34 – $129.57+12% CAGR
2028$65.41 – $95.94+32% CAGR$19.57 – $28.70+7% CAGR$90.11 – $132.16+7% CAGR
2029$82.59 – $121.14+30% CAGR$19.96 – $29.28+5% CAGR$91.91 – $134.80+5% CAGR
2030$104.29 – $152.96+29% CAGR$20.36 – $29.86+4% CAGR$93.75 – $137.50+4% CAGR
2031$131.69 – $193.14+29% CAGR$20.77 – $30.46+4% CAGR$95.62 – $140.25+4% CAGR
5-yr CAGR19.2% – 28.7%-3.7% – 4.0%-3.7% – 4.0%